Cargando…

Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis

BACKGROUND: Rapid diagnostic tests (RDTs) are widely used for diagnosing Plasmodium vivax malaria, especially in resource-limited countries. However, the impact of RDTs on P. vivax malaria incidence and national medical costs has not been evaluated. We assessed the impact of RDT implementation on P....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Ho, Suh, Jiyeon, Lee, Woon Ji, Choi, Heun, Kim, Jong-Dae, Kim, Changsoo, Choi, Jun Yong, Ko, Ryeojin, Kim, Heewon, Lee, Jeehyun, Yeom, Joon Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888375/
https://www.ncbi.nlm.nih.gov/pubmed/33593755
http://dx.doi.org/10.1136/bmjgh-2020-004292
_version_ 1783652149394145280
author Kim, Jung Ho
Suh, Jiyeon
Lee, Woon Ji
Choi, Heun
Kim, Jong-Dae
Kim, Changsoo
Choi, Jun Yong
Ko, Ryeojin
Kim, Heewon
Lee, Jeehyun
Yeom, Joon Sup
author_facet Kim, Jung Ho
Suh, Jiyeon
Lee, Woon Ji
Choi, Heun
Kim, Jong-Dae
Kim, Changsoo
Choi, Jun Yong
Ko, Ryeojin
Kim, Heewon
Lee, Jeehyun
Yeom, Joon Sup
author_sort Kim, Jung Ho
collection PubMed
description BACKGROUND: Rapid diagnostic tests (RDTs) are widely used for diagnosing Plasmodium vivax malaria, especially in resource-limited countries. However, the impact of RDTs on P. vivax malaria incidence and national medical costs has not been evaluated. We assessed the impact of RDT implementation on P. vivax malaria incidence and overall medical expenditures in South Korea and performed a cost–benefit analysis from the payer’s perspective. METHODS: We developed a dynamic compartmental model for P. vivax malaria transmission in South Korea using delay differential equations. Long latency and seasonality were incorporated into the model, which was calibrated to civilian malaria incidences during 2014–2018. We then estimated averted malaria cases and total medical costs from two diagnostic scenarios: microscopy only and both microscopy and RDTs. Medical costs were extracted based on data from a hospital in an at-risk area for P. vivax malaria and were validated using Health Insurance Review and Assessment Service data. We conducted a cost–benefit analysis of RDTs using the incremental benefit:cost ratio (IBCR) considering only medical costs and performed a probabilistic sensitivity analysis to reflect the uncertainties of model parameters, costs and benefits. RESULTS: The results showed that 55.3% of new P. vivax malaria cases were averted, and $696 214 in medical costs was saved over 10 years after RDT introduction. The estimated IBCR was 2.5, indicating that RDT implementation was beneficial, compared with microscopy alone. The IBCR was sensitive to the diagnosis time reduction, infectious period and short latency period, and provided beneficial results in a benefit over $10.6 or RDT cost under $39.7. CONCLUSIONS: The model simulation suggested that RDTs could significantly reduce P. vivax malaria incidence and medical costs. Moreover, cost–benefit analysis demonstrated that the introduction of RDTs was beneficial over microscopy alone. These results support the need for widespread adoption of RDTs.
format Online
Article
Text
id pubmed-7888375
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78883752021-03-03 Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis Kim, Jung Ho Suh, Jiyeon Lee, Woon Ji Choi, Heun Kim, Jong-Dae Kim, Changsoo Choi, Jun Yong Ko, Ryeojin Kim, Heewon Lee, Jeehyun Yeom, Joon Sup BMJ Glob Health Original Research BACKGROUND: Rapid diagnostic tests (RDTs) are widely used for diagnosing Plasmodium vivax malaria, especially in resource-limited countries. However, the impact of RDTs on P. vivax malaria incidence and national medical costs has not been evaluated. We assessed the impact of RDT implementation on P. vivax malaria incidence and overall medical expenditures in South Korea and performed a cost–benefit analysis from the payer’s perspective. METHODS: We developed a dynamic compartmental model for P. vivax malaria transmission in South Korea using delay differential equations. Long latency and seasonality were incorporated into the model, which was calibrated to civilian malaria incidences during 2014–2018. We then estimated averted malaria cases and total medical costs from two diagnostic scenarios: microscopy only and both microscopy and RDTs. Medical costs were extracted based on data from a hospital in an at-risk area for P. vivax malaria and were validated using Health Insurance Review and Assessment Service data. We conducted a cost–benefit analysis of RDTs using the incremental benefit:cost ratio (IBCR) considering only medical costs and performed a probabilistic sensitivity analysis to reflect the uncertainties of model parameters, costs and benefits. RESULTS: The results showed that 55.3% of new P. vivax malaria cases were averted, and $696 214 in medical costs was saved over 10 years after RDT introduction. The estimated IBCR was 2.5, indicating that RDT implementation was beneficial, compared with microscopy alone. The IBCR was sensitive to the diagnosis time reduction, infectious period and short latency period, and provided beneficial results in a benefit over $10.6 or RDT cost under $39.7. CONCLUSIONS: The model simulation suggested that RDTs could significantly reduce P. vivax malaria incidence and medical costs. Moreover, cost–benefit analysis demonstrated that the introduction of RDTs was beneficial over microscopy alone. These results support the need for widespread adoption of RDTs. BMJ Publishing Group 2021-02-16 /pmc/articles/PMC7888375/ /pubmed/33593755 http://dx.doi.org/10.1136/bmjgh-2020-004292 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Kim, Jung Ho
Suh, Jiyeon
Lee, Woon Ji
Choi, Heun
Kim, Jong-Dae
Kim, Changsoo
Choi, Jun Yong
Ko, Ryeojin
Kim, Heewon
Lee, Jeehyun
Yeom, Joon Sup
Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
title Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
title_full Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
title_fullStr Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
title_full_unstemmed Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
title_short Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
title_sort modelling the impact of rapid diagnostic tests on plasmodium vivax malaria in south korea: a cost–benefit analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888375/
https://www.ncbi.nlm.nih.gov/pubmed/33593755
http://dx.doi.org/10.1136/bmjgh-2020-004292
work_keys_str_mv AT kimjungho modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT suhjiyeon modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT leewoonji modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT choiheun modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT kimjongdae modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT kimchangsoo modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT choijunyong modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT koryeojin modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT kimheewon modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT leejeehyun modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis
AT yeomjoonsup modellingtheimpactofrapiddiagnostictestsonplasmodiumvivaxmalariainsouthkoreaacostbenefitanalysis